NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled
NCT00591149 2017-06-14Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerUniversity of Kansas Medical CenterPhase 2 Terminated16 enrolled 5 charts